Meeting
2017 Gastrointestinal Cancers Symposium
Efficacy and safety of taxane-monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: A multicenter retrospective study.
Authors
Sadayuki Kawai
Divison of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
Sadayuki Kawai , Sakura Iizumi , Atsuo Takashima , Yukiya Narita , Masahiro Tajika , Tomohiro Matsushima , Hirofumi Yasui , Kei Muro , Daisuke Takahari , Narikazu Boku
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 154)
DOI
10.1200/JCO.2017.35.4_suppl.154
Abstract #
154
Poster Bd #
L2
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of primary tumor location on efficacy and safety of pembrolizumab (pembro) in patients (pts) with locally advanced or metastatic urothelial carcinoma (UC) enrolled in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-045 trials.
First Author: Peter H. O'Donnell
Poster
2021 Gastrointestinal Cancers Symposium
The association of renal function with safety and efficacy of cisplatin plus S-1 (CS) therapy and docetaxel plus cisplatin plus S-1 (DCS) therapy in patients with advanced gastric cancer (AGC): An exploratory analysis of JCOG1013.
First Author: Shuichi Hironaka
Poster
2020 Gastrointestinal Cancers Symposium
Efficacy and safety of nivolumab and irinotecan as third-line chemotherapy for advanced gastric cancer: A multi-institutional retrospective study.
First Author: Ryosuke Kumanishi